Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01108523
Other study ID # 828-101-09-017
Secondary ID
Status Terminated
Phase Phase 0
First received April 20, 2010
Last updated October 9, 2013
Start date April 2010
Est. completion date February 2012

Study information

Verified date October 2013
Source Healthpoint
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This study evaluates HP828 in the management of moisture associated skin damage after 15 days of use.


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date February 2012
Est. primary completion date July 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- - The informed consent document must be read, signed, and dated by the subject or the subject's legally authorized representative before conducting any study procedures or exams. In addition, the informed consent document must be signed and dated by the individual who consents the subject before conducting Visit 1. A photocopy of the signed informed consent document must be provided to the subject or subject representative, and the original signed document placed in the subject's chart. If the subject is unable to read or sign the informed consent, or unable to comprehend the information provided in the consent process, a legal guardian, decision making proxy, or next of kin must provide written consent, and if possible, subject must verbally assent to receiving an experimental treatment for their wound.

- Are 18 years of age or older, of either sex and of any race or skin type provided that their skin color, in the opinion of the Investigator, will not interfere with the study assessments.

- Are expected to remain in the Nursing Home or long-term acute-care (LTAC) for the duration of the study (15 days).

- Have moisture associated skin damage including denuded skin or ulceration, where:

- the damage has been present for at least 2 days but less than 6 weeks

- the area of denudation (target wound) measures greater than or equal to 2 and less than or equal to 64 cm2 in total area

- the area of total damage may be greater than 64 cm2

- Are able to verbally respond to the Pre- and Post- Treatment Survey.

- Women of child-bearing potential may participate in the study if they have a negative urine pregnancy test and use adequate birth control, as determined by the Investigator.

- Are capable of maintaining adequate nutritional intake during the study

Exclusion Criteria:

- Have more than 64 cm2 of denuded area.

- Have a full-thickness target wound, or a full-thickness wound within 4 cm of any target wound area.

- Have clinical evidence of bacterial or fungal infection of the target wound area.

- Have, within the area of moisture damaged skin, any tunneling, sinus tracks, shear injury, arterial occlusive disease, or bony prominence or joint with the exception that target wounds may be over dorsal spinous processes, coccyx, ischial tuberosities, or sacroiliac joints.

- Are moribund, or have a severe burn, debilitating immunodeficiency disorder, significant hematologic disorder, metastatic malignancy, uncontrolled diabetes mellitus, or any medical conditions that, in the opinion of the Investigator, places the subject at risk for the study or incapable of healing.

- Are known to have acrodermatitis enteropathica (zinc deficiency).

- Are being treated currently with systemic steroids, immunosuppressive agents, radiation, or chemotherapy.

- Have been treated with enzymatic debridement to the target wound area within 2 days prior to enrollment.

- Have a known sensitivity to ingredients of HP828-101.

- Are using or have used another investigational agent (not including devices such as hearing aids, pace makers, etc.) within 30 days prior to Visit 1.

- The Medical Monitor may declare any subject ineligible for a valid medical reason.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
HP828-101


Locations

Country Name City State
United States Golden Acres Dallas Texas

Sponsors (1)

Lead Sponsor Collaborator
Healthpoint

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rating Scores of Skin Erythema, Skin Pallor, Skin Maceration, Skin Denudation at Day 15. 15 Days No
Secondary Rating Scores of Skin Erythema, Skin Pallor, Skin Maceration, Skin Denudation at Day 4, 8, and 12. Proportion of Subjects With no Denuded Skin Area at Day 4, 8, 12, and 15. Pre- and Post-Treatment Surveys 4, 8, 12, and 15 days No
See also
  Status Clinical Trial Phase
Completed NCT04539886 - Comparative Study Between CellFX and Electrodessication in Sebaceous Hyperplasia (SH) Lesions N/A
Completed NCT01407770 - Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Completed NCT05619471 - VIO Imaging for Skin Tissue Assessment (VISTA) N/A
Not yet recruiting NCT05554523 - How Does Skin Tone Affect Quantitative Photoacoustic Imaging
Completed NCT04872946 - Topical and Oral Regimen for Skin Health N/A
Completed NCT04449159 - Efficacy of Vinh Wellness Collagen on Skin Health N/A
Completed NCT03002194 - Change in Skin Elasticity With RF and PEMF N/A
Recruiting NCT06425068 - Assessment of an Innovative Air Mattress On Critically Ill Infants N/A
Enrolling by invitation NCT04934254 - THE NEWBORN SKIN ASSESSMENT ATTITUDE SCALE
Completed NCT05410964 - Non-Linear Imaging of Skin In Vivo
Completed NCT03612570 - Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia N/A
Withdrawn NCT03862872 - Effects of Bend Beauty's Anti-Aging Formula on Inflammatory Markers N/A
Not yet recruiting NCT05923996 - Fractional Co2 Laser Versus Microbotox Injection in the Treatment of Wide Facial Pores: A Split Face Comparative Study Phase 1
Terminated NCT04253418 - Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study N/A
Recruiting NCT04525521 - Hand Sanitizer Effects on the Skin Barrier
Withdrawn NCT01801878 - Pilot Study of Skin Quality Improvement After Adipose-drived Stem Cell Transfer in Irradiated Breasts N/A
Completed NCT00839280 - Moisturizing Effect of Two Dexpanthenol Formulations Phase 2
Completed NCT00520910 - Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers Phase 2
Completed NCT04813887 - Skin Diseases and Pregnancy: Which Heathcare Professionals ?
Recruiting NCT05641168 - A Pilot Evaluation Exploring New Adhesive Materials and Their Ability to Adhere to Abdominal and Peristomal Skin N/A